Skip navigation View an alternate layout of this website with limited styles and no horizontal scrolling
Menu

Alzheimers Skin Patch Receives US Approval

By Rehab Management: Rehab Today,
Publication Date: May 2007

Article focuses on the Exelon Patch, which was designed to deliver effective medicine for patients with mild to moderate Alzheimer’s disease. The Exelon Patch maintains steady drug levels in the bloodstream. It provides significant benefits to patients in terms of their memory and ability to perform everyday tasks as well as helping their overall functioning. It is applied to the back, chest, or upper arm, and provides continuous delivery of medication through the skin over 24 hours. The patch was also approved for treatment of patients with mild to moderate Parkinson’s disease dementia.
Published by: Ascend Media LLC   (Website:http://www.ascendmedia.com)


Link to text: http://www.rehabpub.com/RMN/2007-07-23_06.asp
  • Home
  • Alternate Layout
  • My AbleData
  • Contact
  • Site Map
  • A-Z Index
  • Help
  • Privacy

    • AbleData, 8630 Fenton Street, Suite 930, Silver Spring, MD 20910. 1-800-227-0216.
    Maintained for the National Institute on Disability and Rehabilitation Research of the U.S. Dept. of Education
    by ICF Macro under Contract No. ED-04-CO-0018/0007.

    The records in AbleData are provided for information purposes only. Neither the U.S. Department of Education nor ICF Macro has examined, reviewed, or tested any product, device, or information contained in AbleData. The Department and ICF Macro make no endorsement, representation, or warranty express or implied as to any product, device, or information set forth in AbleData. The views expressed on this site do not necessarily represent the opinions of the Department of Education, the National Institute on Disability and Rehabilitation Research, or ICF Macro.